TY - JOUR
T1 - The Impact of Immunotherapy on Sleep and Circadian Rhythms in Patients with Cancer
AU - Balachandran, Diwakar D.
AU - Bashoura, Lara
AU - Sheshadri, Ajay
AU - Manzullo, Ellen
AU - Faiz, Saadia A.
N1 - Publisher Copyright:
Copyright © 2023 Balachandran, Bashoura, Sheshadri, Manzullo and Faiz.
PY - 2023
Y1 - 2023
N2 - Immunotherapy has revolutionized treatments for both early and advanced cancers, and as their role evolves, their impact on sleep and circadian rhythms continues to unfold. The recognition, evaluation, and treatment of sleep and circadian rhythm disturbance leads to improved symptom management, quality of life and treatment outcomes. An intricate complex relationship exists in the microenvironment with immunity, sleep and the tumor, and these may further vary based on the cancer, addition of standard chemotherapy, and pre-existing patient factors. Sleep and circadian rhythms may offer tools to better utilize immunotherapy in the care of cancer patients, leading to better treatment outcome, reduced symptom burden, and increased quality of life.
AB - Immunotherapy has revolutionized treatments for both early and advanced cancers, and as their role evolves, their impact on sleep and circadian rhythms continues to unfold. The recognition, evaluation, and treatment of sleep and circadian rhythm disturbance leads to improved symptom management, quality of life and treatment outcomes. An intricate complex relationship exists in the microenvironment with immunity, sleep and the tumor, and these may further vary based on the cancer, addition of standard chemotherapy, and pre-existing patient factors. Sleep and circadian rhythms may offer tools to better utilize immunotherapy in the care of cancer patients, leading to better treatment outcome, reduced symptom burden, and increased quality of life.
KW - circadian rhythm
KW - immune checkpoint inhibitors
KW - immunity
KW - immunotherapy
KW - sleep
UR - http://www.scopus.com/inward/record.url?scp=85179310588&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85179310588&partnerID=8YFLogxK
U2 - 10.3389/fonc.2023.1295267
DO - 10.3389/fonc.2023.1295267
M3 - Short survey
C2 - 38090501
AN - SCOPUS:85179310588
SN - 2234-943X
VL - 13
JO - Frontiers in Oncology
JF - Frontiers in Oncology
M1 - 1295267
ER -